J. Larry Jameson | |
---|---|
Interim President of the University of Pennsylvania | |
Acting | |
Assumed office December 12, 2023 | |
Preceded by | Liz Magill |
Personal details | |
Born | James Larry Jameson III |
Education | University of North Carolina at Chapel Hill (BS,MD,PhD) |
Scientific career | |
Fields | Biochemistry,endocrinology |
Institutions | |
Thesis | Regulation of microtubule assembly and steady-state dynamics (1981) |
James Larry Jameson III is an American physician-scientist and endocrinogist, currently serving as interim president of the University of Pennsylvania since December 2023. He has served as the dean of the Perelman School of Medicine and executive vice president of the UPenn Health System since 2011. Jameson's research focuses on gene expression regulation, thyroid disease, and molecular endocrinology.
Jameson was born on Fort Moore in Columbus, Georgia, and raised in Asheville, North Carolina. [1] [2]
From the University of North Carolina at Chapel Hill, Jameson received a Bachelor of Science with a major in chemistry with honors in 1976, a Doctor of Medicine in 1981, and a Doctor of Philosophy in biochemistry in 1981. [3]
Jameson's doctoral dissertation was titled, Regulation of microtubule assembly and steady-state dynamics. [4] During his doctoral studies at UNC, he received the Merck Book Award in 1978, the Alpha Omega Alpha membership in 1980, and the Lange Book Award in 1980. In 1981, he received the Isaac Hall Manning Award and a Merit Award from the UNC School of Medicine. [5]
In 1981, Jameson started as an intern and resident at Massachusetts General Hospital in Boston. In 1983, he became a research fellow at the Howard Hughes Medical Institute's Laboratory of Molecular Endocrinology, studying transcriptional regulation in endocrine genes with a focus on nuclear hormone receptors. [6] [5]
In 1985, Jameson joined Harvard Medical School as an instructor in medicine, advancing to assistant professor in 1987 and associate professor by 1992. [5] During this period, he served as chief of the Thyroid Unit at Massachusetts General Hospital from 1987 to 1993, where he co-directed training programs in endocrinology, diabetes, and reproductive biology. His research included projects on gene expression regulation and hormone receptor interactions with pituitary genes, supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases. [5] In 1990, his contributions were recognized with election to the American Society for Clinical Investigation. [6] [5]
In 1993, Jameson transitioned to Northwestern University's Feinberg School of Medicine as the Charles F. Kettering Professor of Medicine and chief of the Division of Endocrinology, Metabolism, and Molecular Medicine. He directed Northwestern’s Training Program in Endocrinology and Metabolism, focusing on endocrine gene transcription, thyroid disease, and pituitary tumor pathogenesis. He was elected a member of the Association of American Physicians in 1995. That same year, he began contributing as co-editor-in-chief of the textbook, Endocrinology, a reference work on clinical and molecular endocrinology. [6] [5]
In 2000, Jameson became chairman of the Department of Medicine at Northwestern University, overseeing a broad range of research initiatives and patient care services across multiple specialties. He directed the Hormone Action and Cancer Group at the Robert H. Lurie Comprehensive Cancer Center, continuing his research into hormone receptor action and cancer biology. In 2004, Jameson was elected as a fellow of the American Academy of Arts and Sciences and became a fellow of the American Association for the Advancement of Science in 2005. The following year, he was inducted into the National Academy of Medicine. [6] [5]
In 2007, Jameson was appointed dean of the Feinberg School of Medicine and vice president for medical affairs at Northwestern University. In these roles, he expanded research initiatives and emphasized molecular medicine in education. That same year, he also joined Harrison’s Principles of Internal Medicine as an editor, contributing to its 15th through 21st editions and authoring sections on endocrinology, genetics, and sex development. [5]
In 2011, Jameson joined the University of Pennsylvania, serving as the executive vice president for the University of Pennsylvania Health System and Dean of the Perelman School of Medicine at the University of Pennsylvania. His responsibilities included expanding research and clinical infrastructure and directing strategic growth in medical education. His editorial roles further expanded as he became editor-in-chief of The Journal of Clinical Endocrinology and Metabolism from 2016 to 2021, and editor-in-chief of Journal of the Endocrine Society from 2016 to 2019.
In December 2023, Jameson was appointed interim president of the University of Pennsylvania, following the resignation of Liz Magill amid her congressional hearing controversies. [7] He will continue in that role until at least 2026. [8] [9]
Jameson's paternal lineage traces back to his great-great-great grandfather, William Jameson Sr., who emigrated from Ireland to colonial America in 1750. [1] William Jameson settled in Easley, South Carolina, and served in the American Revolutionary War. [1] For four subsequent generations, the family remained in South Carolina until Jameson's father relocated to Asheville, North Carolina, where Jameson was raised. [1]
Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. Specializations include behavioral endocrinology and comparative endocrinology.
The Perelman School of Medicine is the medical school of the University of Pennsylvania, a private, Ivy League research university located in Philadelphia. Founded in 1765, the Perelman School of Medicine is the oldest medical school in the United States. Today, the Perelman School of Medicine is a major center of biomedical research and education with over 2,900 faculty members and nearly $1 billion in annual sponsored program awards.
The Endocrine Society is a professional, international medical organization in the field of endocrinology and metabolism, founded in 1916 as The Association for the Study of Internal Secretions. The official name of the organization was changed to the Endocrine Society on January 1, 1952. It is a leading organization in the field and publishes four leading journals. It has more than 18,000 members from over 120 countries in medicine, molecular and cellular biology, biochemistry, physiology, genetics, immunology, education, industry, and allied health. The Society's mission is: "to advance excellence in endocrinology and promote its essential and integrative role in scientific discovery, medical practice, and human health."
The thyroid hormone receptor (TR) is a type of nuclear receptor that is activated by binding thyroid hormone. TRs act as transcription factors, ultimately affecting the regulation of gene transcription and translation. These receptors also have non-genomic effects that lead to second messenger activation, and corresponding cellular response.
The sodium/iodide cotransporter, also known as the sodium/iodide symporter (NIS), is a protein that in humans is encoded by the SLC5A5 gene. It is a transmembrane glycoprotein with a molecular weight of 87 kDa and 13 transmembrane domains, which transports two sodium cations (Na+) for each iodide anion (I−) into the cell. NIS mediated uptake of iodide into follicular cells of the thyroid gland is the first step in the synthesis of thyroid hormone.
The University of North Carolina School of Medicine is the medical school of the University of North Carolina at Chapel Hill. It offers a Doctor of Medicine degree along with combined Doctor of Medicine / Doctor of Philosophy or Doctor of Medicine / Master of Public Health degrees.
Bert W. O'Malley is an endocrinologist from the United States. He was born in 1936 in the Garfield section of Pittsburgh, Pennsylvania. He received his early education at Catholic primary schools and Central Catholic High School, before pursuing higher education at the University of Pittsburgh, where he completed both his undergraduate and medical studies, graduating first in his class. It was here that he met Sally, who would become his wife and lifelong partner. The couple went on to have four children.
Thyroid hormones are any hormones produced and released by the thyroid gland, namely triiodothyronine (T3) and thyroxine (T4). They are tyrosine-based hormones that are primarily responsible for regulation of metabolism. T3 and T4 are partially composed of iodine, derived from food. A deficiency of iodine leads to decreased production of T3 and T4, enlarges the thyroid tissue and will cause the disease known as simple goitre.
Dr. Hossein Gharib is a physician who specializes in thyroid disorders. He was born in Tehran, Iran, on February 2, 1940, and is a consulting physician at the Mayo Clinic in Rochester, Minnesota.
Mitchell Lazar is an endocrinologist and physician-scientist known for his discovery of the hormone resistin and his contributions to the transcriptional regulation of metabolism.
John Kopchick is a molecular biologist and co-inventor of the drug Somavert (Pegvisomant), which has improved the lives of acromegalic individuals around the world. He is currently the Goll-Ohio Eminent Scholar and Professor of Molecular Biology in the Department of Biomedical Sciences at the Ohio University Heritage College of Osteopathic Medicine. Dr. Kopchick's groundbreaking work in the field of growth hormone has helped shape the study of endocrinology.
Maria Iandolo New(1928-2024) was a professor of Pediatrics, Genomics and Genetics at Icahn School of Medicine at Mount Sinai in New York City. She is an expert in congenital adrenal hyperplasia (CAH), a genetic condition affecting the adrenal gland that can affect sexual development.
James M. Wilson is an American biomedical researcher and CEO of two biotech companies, Gemma Biotherapeutics and Franklin Biolabs, focused on gene therapies. He previously served as the Director of the Gene Therapy Program, Rose H. Weiss Professor and Director of the Orphan Disease Center, and Professor of Medicine and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Previously, he held the John Herr Musser endowed professorship at the Perelman School of Medicine.
Retinal vasculopathy with cerebral leukocencephalopathyand systemic manifestations is an inherited condition resulting from a frameshift mutation in the C-terminal region of the TREX1 gene.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Teresa Kaye Woodruff is an American medical researcher in human reproduction and oncology, with a focus on ovarian biology, endocrinology, and women's health. She joined Michigan State University as the Provost and Executive Vice President for Academic Affairs in August 2020. Woodruff served as the interim President of Michigan State University from November 4, 2022 to March 4, 2024, following the resignation of Samuel L. Stanley. She was previously the Thomas J. Watkins Memorial Professor and Vice Chair for Research and Chief of the Division of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Sheue-yann Cheng is an American molecular geneticist who pioneered the development of mouse models to understand the molecular basis of diseases due to mutations of thyroid hormone receptors. Cheng is a senior investigator at the National Cancer Institute and chief of the gene regulation section.
Gaetano "Nino" Salvatore was an Italian endocrinologist known for his extensive research on the thyroid gland. He spent the majority of his career in Naples' Stazione Zoologica and the University of Naples Federico II, while also spending periods at the American National Institutes of Health and in France.
Jonathan A. Epstein is an American cellular biologist, cardiologist, and academic administrator serving as the interim executive vice president of the University of Pennsylvania Health System and dean of the Raymond and Ruth Perelman School of Medicine since 2023.
Michael A. Levine is an American physician, scientist, academic, and author. He is an emeritus Professor of Pediatrics and Medicine in the Perelman School of Medicine at the University of Pennsylvania.
{{cite web}}
: CS1 maint: multiple names: authors list (link){{cite web}}
: CS1 maint: multiple names: authors list (link)